Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520

Overview of attention for article published in Targeted Oncology, February 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 1,228 followers.

Two studies on a novel Focal Adhesion Kinase inhibitor just got published: with a strong contribution from @ErasmusOncology https://t.co/E461RuLQXE https://t.co/DB6G3I2YQn

19 Feb 2019

Reply Repost Favourite

RT @martijn_lolkema: Back 2 Back publication of a two #PhaseI trials of a Focal Adhesion Kinase inhibitor. @Boehringer @ErasmusOncology @NK…

13 Feb 2019

Reply Repost Favourite

Back 2 Back publication of a two #PhaseI trials of a Focal Adhesion Kinase inhibitor. @Boehringer @ErasmusOncology @NKI_nl @UMCUtrecht @pmcancercentre Juravinski Cancer Centre. Successful Canadian/ Dutch collaboration. https://t.co/nEpC01Zped https://t.c

13 Feb 2019

Reply Repost Favourite

Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520 https://t.co/jczCZGqs9S https://t.co/7octn5kWkH

12 Feb 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.